Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q4 2016 · 10-K
Revenue$2.87B$2.87B+1.2% vs Q4 2015 Net Income$649.20M$649.20M−21.9% vs Q4 2015 EPS Diluted$2.99$2.99−20.7% vs Q4 2015 Gross Profit$2,493,500,000−0.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$1,581,900,000+27.2% Free Cash Flowderived$1,399,800,000+32.4% Margins · derivedGross margin86.8%−1.5 pt vs Q4 2015
Operating margin30.9%−10.2 pt vs Q4 2015
Net margin22.6%−6.7 pt vs Q4 2015
ended Dec 31, 2016 · filed Feb 2, 2017 · 33 d after period end